Retail News

FDA Warns Bayer Over Aspirin Product Claims

The Associated Press/Forbes.com 10/28/2008

The Food and Drug Administration has sent warning letters to Bayer claiming the company never submitted proof that its Women’s Low Dose Aspirin + Calcium and Bayer Aspirin with Health Advantage are effective in treating heart disease or osteoporosis.

MORE ON THIS STORY...

MORE RETAIL NEWS HEADLINES...

Discussions
Check out RetailWire's Engaging Online Discussions Featuring Our Exclusive Braintrust!